A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

"Although the effect on overall anaemia did not differ, intravenous iron reduced the prevalence of iron deficiency to a ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Diabetes, prediabetes, and hyperglycemia were linked to accelerated brain aging, but physical activity and abstention from ...